Please login to the form below

Not currently logged in
Email:
Password:

Spiolto Respimat

This page shows the latest Spiolto Respimat news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim returns to growth after US turnaround

Boehringer Ingelheim returns to growth after US turnaround

fibrosis treatmentRespimat in COPD and Spiriva Respimat for asthma.

Latest news

  • Boehringer hails its 'landmark year' in respiratory Boehringer hails its 'landmark year' in respiratory

    We are also looking at Spiriva Respimat in paediatric asthma patients because there is an unmet medical need there.”. ... Spiolto is positioned as offering greater benefits for patients and physicians than Spiriva and was approved in its first European

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...